Therapeutic options following pneumonectomy in non-small cell lung cancer

References

• Fell SC. Special article: a brief history of pneumonectomy. 1999. Chest Surg Clin N Am. 2002 Aug;12(3):541–563.
   PubMedGoogle Scholar
• Carlens E. A new flexible double-lumen catheter for bronchospirometry. J Thorac Surg. 1949;18:742–746.
   PubMedGoogle Scholar
• Bjork VO, Carlens E. The prevention of spread during pulmonary resection by the use of a double-lumen catheter. J Thorac Surg. 1950;20:151–157.
   PubMedGoogle Scholar
• Melloul E, Egger B, Krueger T, et al. Mortality, complications and loss of pulmonary function after pneumonectomy vs. Sleeve Lobectomy in Patients Younger and Older than 70 Years. Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):986–989.
   PubMedGoogle Scholar
• Kirby TJ, Fell SC. Pneumonectomy and its modifications in: general thoracic surgery. 6th ed. Vol. 1, Chapter 29. Philadelphia (PA): Lippincottt Williams & Wilkins; 2005. p. 470–485.
   Google Scholar
• Waters PF. Pneumonectomy in: Pearson’s thoracic & esophageal surgery. 3rd ed. Vol. Chapter 70. Philadelphia (PA): Churchill Livingstone Elsevier; 2008. Vol. 1. p. 864–868.
   Google Scholar
• Casiraghi M, Maisonneuve P, Brambilla D, et al. The role of extended pulmonary metastasectomy. J Thorac Oncol. 2015 Jun;10(6):924–929.
   PubMed Web of Science ®Google Scholar
• Spaggiari L, Marulli G, Bovolato P, et al. Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study. Ann Thorac Surg. 2014 Jun;97(6):1859–1865.
   PubMed Web of Science ®Google Scholar
• Stamatis G, Welter S, Mercier O, et al. Pneumonectomy in: ESTS textbook of thoracic surgery. 1st ed. Vol. 1, Chapter 55.8. Cracow: Medycyna Praktyczna; 2014. p. 847–960.
   Google Scholar
• Venuta F, Rendina EA. Bronchial sleeve resection in: ESTS textbook of thoracic surgery. 1st ed. Vol. 1, Chapter 55.5. Cracow: Medycyna Praktyczna; 2014. p. 913–921.
   Google Scholar
• Leo F, Spaggiari L. Radical pneumonectomy. In: Atlas of advanced operative surgery Elsevier Saunders chapter 5. Amsterdam: Elsevier; 2013. p. 36–42.
   Google Scholar
• Terzi A, Lonardoni A, Scanagatta P, et al. Lung resection for bronchogenic carcinoma after pneumonectomy: a safe and worthwhile procedure. Eur J Cardiothorac Surg. 2004 Mar;25(3):456–459.
   PubMed Web of Science ®Google Scholar
• Toufektzian L, Patris V, Potaris K. Konstantinou M Is it safe and worthwhile to perform pulmonary resection after contralateral pneumonectomy? Interact Cardiovasc. Thorac Surg. 2015 Feb;20(2):265–269.
   Web of Science ®Google Scholar
• Grodzki T, Alchimowicz J, Kozak A, et al. Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results. Eur J Cardiothorac Surg. 2008 Sep;34(3):493–498.
   PubMed Web of Science ®Google Scholar
• Donington JS, Miller DL, Rowland CC, et al. Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg. 2002;74(1):154–158. discussion 158-9.
   PubMed Web of Science ®Google Scholar
• Spaggiari L, Grunenwald D, Girard P, et al. Cancer resection on the residual lung after pneumonectomy for bronchogenic carcinoma. Ann Thorac Surg. 1996 Dec;62(6):1598–1602.
   PubMed Web of Science ®Google Scholar
• Spaggiari L, Rusca M, Carbognani P, et al. Segmentectomy on a single lung by femorofemoral cardiopulmonary bypass. Ann Thorac Surg. 1997 Nov;64(5):1519.
   PubMed Web of Science ®Google Scholar
• Gillon SA, Toufektzian L, Harrison-Phipps K, et al. Perioperative extracorporeal membrane oxygenation to facilitate lung resection after contralateral pneumonectomy. Ann Thorac Surg. 2016;101(3):e71–3.
   PubMed Web of Science ®Google Scholar
• Wright CD, Wain JC, Mathisen DJ, et al. Postpneumonectomy bronchopleural fistula after sutured bronchial closure: incidence, risk factors, and management. J Thorac Cardiovasc Surg. 1996 Nov;112(5):1367–1371.
   PubMed Web of Science ®Google Scholar
• Bisdas T, Beutel G, Warnecke G, et al. Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg. 2011;92(2):626–631. Epub 2011 May 8.
   PubMed Web of Science ®Google Scholar
• Murphy DA, Hockings LE, Andrews RK, et al. Extracorporeal membrane oxygenation-hemostatic complications. Transfus Med Rev. 2015;29(2):90–101. Epub 2014 Dec 18.
   PubMed Web of Science ®Google Scholar
• Petrella F, Spaggiari L, Acocella F, et al. Airway fistula closure after stem-cell infusion. N Engl J Med. 2015 Jan 1;372(1):96–97.
   PubMed Web of Science ®Google Scholar
• Jung JJ, Cho JH, Kim HK, et al. Management of post-pneumonectomy syndrome using tissue expanders. Thorac Cancer. 2016 Jan;7(1):88–93.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Faivre-Finn C, Nestle U, et al. European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol. 2010 Dec 20;28(36):5301–5310.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010 Mar 17;303(11):1070–1076.
   PubMed Web of Science ®Google Scholar
• Palma D, Lagerwaard F, Rodrigues G, et al. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1149–1156.
   PubMed Web of Science ®Google Scholar
• Testolin A, Favretto MS, Cora S, et al. Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicity. Br J Radiol. 2015;88(1055):20150228.
   PubMed Web of Science ®Google Scholar
• Haasbeek CJ, Lagerwaard FJ, De Jaeger K, et al. Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy. Cancer. 2009 Feb 1;115(3):587–594.
   PubMed Web of Science ®Google Scholar
• Senthi S, Haasbeek CJ, Lagerwaard FJ, et al. Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. J Thorac Dis. 2013 Apr;5(2):116–122.
   PubMed Web of Science ®Google Scholar
• Thompson R, Giuliani M, Yap ML, et al. Stereotactic body radiotherapy in patients with previous pneumonectomy: safety and efficacy. J Thorac Oncol. 2014;9(6):843–847.
   PubMed Web of Science ®Google Scholar
• Machtay M, Lee JH, Shrager JB, et al. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol. 2001 Oct 1;19(19):3912–3917.
   PubMed Web of Science ®Google Scholar
• Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol. 2006 Jul 1;24(19):2998–3006.
   PubMed Web of Science ®Google Scholar
• Kim H, Lussier YA, Noh OK, et al. Prognostic implication of pulmonary function at the beginning of postoperative radiotherapy in non-small cell lung cancer. Radiother Oncol. 2014 Dec;113(3):374–378.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Naguib NN, Lehnert T, et al. Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations–review article. Eur J Radiol. 2011 Feb;77(2):346–357. Epub 2009 Aug 22.
   PubMed Web of Science ®Google Scholar
• Hess A, Palussière J, Goyers JF, et al. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology. 2011 Feb;258(2):635–642.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000 Jan;174(1):57–59.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, May B, Petre EN, et al. Pulmonary thermal ablation in patients with prior pneumonectomy. AJR Am J Roentgenol. 2011 May;196(5):W606–12.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Bergman B, Dunant A, et al. International adjuvant lung cancer trial collaborative group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004 Jan 22;350(4):351–360.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Dunant A, Pignon JP, et al. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer. J Clin Oncol. 2010 Jan 1;28(1):35–42.
   PubMed Web of Science ®Google Scholar
• Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006 Sep;7(9):719–727.
   PubMed Web of Science ®Google Scholar
• Winton T, Livingston R, Johnson D, et al. National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med. 2005 Jun 23;352(25):2589–2597.
   PubMed Web of Science ®Google Scholar
• Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, radiation therapy oncology group, and North Central Cancer treatment group study groups. J Clin Oncol. 2008 Nov 1;26(31):5043–5051.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Tribodet H, Scagliotti GV, et al. LACE collaborative group lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J Clin Oncol. 2008 Jul 20;26(21):3552–3559.
   PubMed Web of Science ®Google Scholar
• Berry MF, Coleman BK, Curtis LH, et al. Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients. Ann Surg Oncol. 2015 Feb;22(2):642–648.
   PubMed Web of Science ®Google Scholar
• Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5Suppl):e314S–40S.
   PubMed Web of Science ®Google Scholar
• Graeter TP, Sebastian B, Bischof M, et al. Analysis of patients unable to undergo adjuvant chemotherapy after surgery in stage IIIA/B non-small cell lung cancer: will they benefit from mediastinal radiotherapy? Thorac Cardiovasc Surg. 2015 Aug 31. [Epub ahead of print]
   PubMedGoogle Scholar
• Albain KS, Swann RS, Rusch VW, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009 Aug 1;374(9687):379–386.
   PubMed Web of Science ®Google Scholar
• Alam N, Shepherd FA, Winton T, et al. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer. 2005 Mar;47(3):385–394.
   PubMed Web of Science ®Google Scholar
• Qadri SS, Chaudhry MA, Cale A, et al. Short- and long-term outcomes of pneumonectomy in a tertiary center. Asian Cardiovasc Thorac Ann. 2016 Mar;24(3):250–256.
   PubMedGoogle Scholar
• Leo F, Solli P, Veronesi G, et al. Does chemotherapy increase the risk of respiratory complications after pneumonectomy? J Thorac Cardiovasc Surg. 2006 Sep;132(3):519–523.
   PubMed Web of Science ®Google Scholar